Tanalys

Market Notice 234/24 – Information regarding the rights issue from ODI Pharma AB

Pending decision at the Extraordinary General Meeting on November 19, 2024, the last day of trading in the company’s shares ODI including the right to receive subscription rights is November 20, 2024. The first day excluding the right to obtain the rights is November 21, 2024. 

One (1) share entitles the owner to one (1) subscription right. Twelve (12) subscription rights entitle the owner to subscribe for one (1) new share, at the price of SEK 3,22 (1:12 á SEK 3,22).   

The subscription period lasts from November 26, 2024, to December 10, 2024. 

Information about the subscription right:   

Short name: ODI TR  
ISIN-code: SE0023312996 
Orderbook-ID: 371208 
CFI: RSSXXR 
FISN: ODIPHARMA/SUBS RTS NL PD 
First day of trading: November 26, 2024 
Last day of trading: December 5, 2024 
Market Segment: SPSE 
MIC Code: XSAT 
Tick size: 2   

Information about the paid subscribed share:  

Shortname: ODI BTA  
ISIN-code: SE0023313002 
Orderbook-ID: 371209 
CFI: ESNUFR 
FISN: ODIPHARMA/SH 
Trading period: November 26, 2024 until the registration of the issue at Bolagsverket.  
Market Segment: SPSE 
MIC Code:  XSAT 
Tick size: 2   

Please be advised that if the rights issue give rise to a conversion factor, all overnight orders in the company’s order book will be flushed. If so this will occur after closing on November 20, 2024. 

Stockholm November 15 2024 

Spotlight Stock Market 
08-51168000   
backoffice@spotlightstockmarket.com

Exit mobile version